|
 |
| LETTERS TO THE EDITOR |
|
| Year : 2018 | Volume
: 11
| Issue : 3 | Page : 308 |
|
|
Authors' reply: Subfoveal choroidal thickness measurements in spectral-domain and swept-source optical coherence tomography devices
George J Manayath1, Sidharth Narendran2
1 Department of Retina, Aravind Eye Hospital and Postgraduate Institute, Coimbatore, Tamil Nadu, India
2 Department of Retina, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India
| Date of Web Publication | 29-Oct-2018 |
Correspondence Address:
Dr. George J Manayath
Department of Retina, Aravind Eye Hospital and Postgraduate Institute, Coimbatore, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ojo.OJO_175_2018
How to cite this article:
Manayath GJ, Narendran S. Authors' reply: Subfoveal choroidal thickness measurements in spectral-domain and swept-source optical coherence tomography devices. Oman J Ophthalmol 2018;11:308 |
How to cite this URL:
Manayath GJ, Narendran S. Authors' reply: Subfoveal choroidal thickness measurements in spectral-domain and swept-source optical coherence tomography devices. Oman J Ophthalmol [serial online] 2018 [cited 2022 Mar 6];11:308. Available from: https://www.ojoonline.org/text.asp?2018/11/3/308/244312 |
Sir,
We thank authors for the interest shown in our study. We agree that the automated chorio-scleral interface (CSI) detection increases the disparity between the two devices and also that the repeatability of the automated CSI detection feature is inferior to manual segmentation (data not published in our article). We also acknowledge the discrepancy in our Table 1 in relation to the Tan et al.'s study and the difference in measurement techniques of central subfield thickness and automated segmentation of CSI boundaries used in their study. We appreciate the authors for bringing up these points for discussion and highlighting the importance of our results.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| This article has been cited by | | 1 |
3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization |
|
| Yu-Chen Hu, Yi-Ling Chen, Yen-Chih Chen, San-Ni Chen | | Scientific Reports. 2021; 11(1) | | [Pubmed] | [DOI] | | | 2 |
Relationship of Choroidal Vasculature and Choriocapillaris Flow With Alterations of Salivary a-Amylase Patterns in Central Serous Chorioretinopathy |
|
| Fabio Scarinci, Francesca Romana Patacchioli, Eliana Costanzo, Mariacristina Parravano | | Investigative Opthalmology & Visual Science. 2021; 62(15): 19 | | [Pubmed] | [DOI] | | | 3 |
Systemic evaluation of patients with central serous chorioretinopathy: A case-control study |
|
| Devesh Kumawat, Alok Kumar Ravi, Pranita Sahay, Tanveer Alam, Arjun Desai, Atul Kumar | | European Journal of Ophthalmology. 2021; 31(6): 3223 | | [Pubmed] | [DOI] | | | 4 |
Posterior choroidal fluid loculation in central serous chorioretinopathy presenting as a choroidal elevation: A rare Pachychoroid phenotype |
|
| George J Manayath, Reshma Balan, Ratnesh Ranjan, Veerappan R Saravanan, Venkatapathy Narendran | | European Journal of Ophthalmology. 2021; : 1120672121 | | [Pubmed] | [DOI] | | | 5 |
Long-term outcomes of half-fluence photodynamic therapy and eplerenone in chronic central serous chorioretinopathy: A comparative study |
|
| George Manayath, Shishir Verghese, Ratnesh Ranjan, Hitesh Agrawal, Amishi Khanna, Venkatapathy Narendran, Jay Chhablani | | European Journal of Ophthalmology. 2021; 31(6): 3110 | | [Pubmed] | [DOI] | |
|
 |
 |
|
Search Pubmed for